pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

312 catalysts · 3,057 8k filing · 576 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 28 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×from 2026-04-07×clear all
type
  • 8k filing3,057
  • earnings576
  • grant184
  • phase 2 completion172
  • drug shortage133
  • approval128
phase 1 completion
73
  • device 510k68
  • phase 2 initiation62
  • recall52
  • therapy area

    no tagged catalysts yet

    Week of Apr 6, 2026

    50
    ›Apr 7, 2026approval126d agoNITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN) — FDA approvalCreekwood Pharmaceutical Inc

    Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 7, 2026approval126d agoBEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalnirsevimab

    Sponsor: ASTRAZENECA AB. Form: INJECTABLE. Route: INJECTION

    full page →nirsevimab →fda approvals ↗
    ›Apr 7, 2026approval126d agoPLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvallutetium Lu 177 vipivotide tetraxetan

    Sponsor: NOVARTIS. Form: SOLUTION. Route: INTRAVENOUS

    full page →lutetium Lu 177 vipivotide tetraxetan →fda approvals ↗
    ›Apr 7, 2026approval126d agoIVERMECTIN — FDA approvalIVERMECTIN

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →IVERMECTIN →fda approvals ↗
    ›Apr 7, 2026approval126d agoSKYCLARYS (OMAVELOXOLONE) — FDA approvalReata Pharmaceuticals Inc

    Sponsor: BIOGEN US. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 7, 2026approval126d agoCEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approvalSamson Medical Technologies LLC

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 7, 2026approval126d agoEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE) — FDA approvalemtricitabine

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →emtricitabine →fda approvals ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Durability of memory T cell responses in melanoma

    CA grant. $660,808. PI: Christina Vadala Angeles

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoCORNELL UNIVERSITY — Understanding the mechanisms of maternal antibody interference with oral vacc...

    AI grant. $653,742. PI: Sarah Caddy

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoYALE UNIVERSITY — Investigating mechanisms of CD8 T cell differentiation in the tumor-draining ...

    CA grant. $696,189. PI: Nikhil Joshi

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF TEXAS AT AUSTIN — Functions of caldendrin in sensory neurons

    NS grant. $613,161. PI: AMY LEE

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoCALIFORNIA STATE UNIVERSITY FULLERTON — Cellular and molecular mechanisms of BPA-induced disruption of neurodevelopment

    ES grant. $400,398. PI: Adam Christopher Roberts

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoCLEVELAND CLINIC LERNER COM-CWRU — Discerning the role of CDK10 in driving aggressiveness and disparities of tri...

    CA grant. $403,686. PI: RUTH A. KERI

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoSTATE UNIVERSITY OF NEW YORK AT BUFFALO — Identifying the functional impact of ZNF688 autoantibodies in oral lupus lesions

    AI grant. $160,100. PI: LEE ANN Garrett-Sinha

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF CALIFORNIA-IRVINE — Type 1 Innate Lymphoid Cells: Mechanisms and Anti-AML Potential

    CA grant. $586,364. PI: Jianhua Yu

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoXAVIER UNIVERSITY — Building Capacity in Biomedical Research at Xavier University

    GM grant. $389,203. PI: Mary K Kochlefl

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoYALE UNIVERSITY — Dissecting the protective and pathogenic functions of Tbet+CD11c+ B cells in ...

    AI grant. $50,114. PI: Adrianna Jones

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Inactivation of the ISR/ATF4 signaling pathway stabilizes HIV reservoirs

    MH grant. $793,185. PI: Guochun Jiang

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Modeling Dirty Timestamp Mice to Assess the Impact of Perinatal Exposure to D...

    AI grant. $411,078. PI: Yasmina Laouar

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Development of miRNA-based approach for pediatric high-grade gliomas

    CA grant. $544,520. PI: Tohru Yamada

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Enhancing Host Defense Against Bacterial Pneumonia in Lipodystrophy: Evaluati...

    AI grant. $429,000. PI: PETER MANCUSO

    full page →nih reporter ↗
    ›Apr 7, 2026grant126d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Volumetric ultrasound for functional imaging and multi-targeted closed-loop c...

    EB grant. $570,612. PI: Charles F Caskey

    full page →nih reporter ↗
    ›Apr 8, 2026approval125d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Apr 8, 2026approval125d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 8, 2026approval125d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 8, 2026approval125d agoINGREZZA SPRINKLE (VALBENAZINE TOSYLATE) — FDA approvalVALBENAZINE TOSYLATE

    Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL

    full page →VALBENAZINE TOSYLATE →fda approvals ↗
    ›Apr 8, 2026approval125d agoHALOPERIDOL — FDA approvalHALOPERIDOL

    Sponsor: AIPING PHARM INC. Form: TABLET. Route: ORAL

    full page →HALOPERIDOL →fda approvals ↗
    ›Apr 8, 2026approval125d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

    Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 8, 2026approval125d agoOFLOXACIN — FDA approvalOFLOXACIN

    Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →OFLOXACIN →fda approvals ↗
    ›Apr 8, 2026approval125d agoPROGESTERONE — FDA approvalPROGESTERONE

    Sponsor: GLENMARK PHARMS LTD. Form: INSERT. Route: VAGINAL

    full page →PROGESTERONE →fda approvals ↗
    ›Apr 8, 2026approval125d agoELTROMBOPAG OLAMINE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ZENARA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 8, 2026grant125d agoWASHINGTON UNIVERSITY — Transcriptomic Signatures of Ischemic Stroke: Unlocking Human-Specific Target...

    NS grant. $231,264. PI: Destiny Hooper

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Development of full thickness human skin model for investigating the mechanis...

    AI grant. $556,457. PI: Asim Ejaz

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Restoring Cognitive Flexibility After Adolescent Cocaine Exposure Using Psilo...Albert Einstein College of Medicine

    DA grant. $50,114. PI: Julia Rose Benville

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoTEMPLE UNIV OF THE COMMONWEALTH — Genetic method to selectively lesion axons or prune axonal terminals

    NS grant. $237,750. PI: George M Smith

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoINDIANA UNIVERSITY INDIANAPOLIS — DLK1 Promotes Tumorigenesis and is a Biomarker for MPNST

    NS grant. $613,912. PI: David W Clapp

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityCity of Hope

    AI grant. $794,183. PI: Zuoming Sun

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoCARNEGIE-MELLON UNIVERSITY — Somatostatin neurons and learning

    NS grant. $455,645. PI: ALISON L BARTH

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A Day in the Life of the Human Brain: Investigating the Dynamic Interrelation...

    MH grant. $1,004,971. PI: AVNIEL S GHUMAN

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoYALE UNIVERSITY — Serotype re-emergence and vaccine impact in the era of next-generation pneumo...

    AI grant. $792,513. PI: Daniel Martin Weinberger

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIVERSITY OF KANSAS MEDICAL CENTER — Pre-Clinical Evaluation of a Highly Selective SMARCA2 Degrader in Therapy-Res...University of Kansas Medical Center

    CA grant. $398,544. PI: Priyanka Sharma

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoSRI INTERNATIONAL — Development and Support of the Pathway Tools SoftwareSRI International

    AI grant. $1,219,508. PI: PETER D KARP

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIV OF NORTH CAROLINA CHAPEL HILL — MASTL Kinase in DNA Repair and Treatment Resistance in Oral Squamous Cell Car...

    DE grant. $42,358. PI: Odjo Gouttia

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Proline tRNA biogenesis as oncogenic drivers and therapeutic target in T cell...

    CA grant. $473,372. PI: Palaniraja Thandapani

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoHEALTHPARTNERS INSTITUTE — Data-driven Development of Clinically Translatable EHR-Based Models to Estima...

    MH grant. $199,747. PI: Kathleen Miley

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoFRED HUTCHINSON CANCER CENTER — Investigating the impact of type I IFN signaling on regulatory T cell functio...

    AI grant. $49,343. PI: Lakshmi S Warrier

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoSTANFORD UNIVERSITY — Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Imm...Stanford University

    AI grant. $809,250. PI: Katja Gabriele Weinacht

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUT SOUTHWESTERN MEDICAL CENTER — Mentoring in Translational Research in Inflammatory Skin Disease

    AR grant. $123,108. PI: Tamia Alisha Harris-Tryon

    full page →nih reporter ↗
    ›Apr 9, 2026approval124d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

    Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

    full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗
    ›Apr 9, 2026approval124d agoVABYSMO (FARICIMAB-SVOA) — FDA approvalfaricimab

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL

    full page →faricimab →fda approvals ↗
    ← prev
    page 1 of 7
    next →
    $RDHL0.7390+6.64%
    $NVS156.79+0.29%
    $NBIX164.92+0.92%
    $AMRX17.88-1.43%
    $RDY12.15-0.57%
    $AZN161.91+0.30%